Short and Long-Term Effects of the Angiotensin II Receptor Blocker Irbesartan on Intradialytic Central Hemodynamics: A Randomized Double-Blind Placebo-Controlled One-Year Intervention Trial (the SAFIR Study).
Autor: | Christian Daugaard Peters, Krista Dybtved Kjaergaard, Jens Dam Jensen, Kent Lodberg Christensen, Charlotte Strandhave, Ida Noerager Tietze, Marija Kristina Novosel, Bo Martin Bibby, Bente Jespersen |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2015 |
Předmět: | |
Zdroj: | PLoS ONE, Vol 10, Iss 6, p e0126882 (2015) |
Druh dokumentu: | article |
ISSN: | 1932-6203 |
DOI: | 10.1371/journal.pone.0126882 |
Popis: | Little is known about the tolerability of antihypertensive drugs during hemodialysis treatment. The present study evaluated the use of the angiotensin II receptor blocker (ARB) irbesartan.Randomized, double-blind, placebo-controlled, one-year intervention trial.Eighty-two hemodialysis patients with urine output >300 mL/day and dialysis vintage |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |
Pro tento záznam nejsou dostupné žádné jednotky.